The Bill and Melinda Gates Foundation's Global Health Programme granted a £20 million award to establish the SCI at Imperial College London, under the leadership of Professor Alan Fenwick. The grant allowed the SCI to provide a proof-of-concept for national-scale schistosomiasis programmes. It assisted the Ministries of Health and Education to deliver treatment for schistosomiasis and soil-transmitted helminthiasis in 6 countries, targeting school-age children and adults at high risk of infection.
Global network for ntds
The SCI became a founding partner of the Global Network for Neglected Tropical Diseases which promoted the integration of control or elimination programmes against seven NTDs.
40 million treatments delivered
By 2007, the SCI had facilitated the delivery of approximately 40 million treatments of praziquantel against schistosomiasis, and many more deworming doses of albendazole.
The SCI expanded its reach after the award of the management of ICOSA (Integrated Control of Schistosomiasis and Intestinal Helminths in sub-Saharan Africa) - a programme funded by the UK Government's Department for International Development (DFID).
100 million treatments delivered
The SCI announced that it had facilitated the delivery of its 100 millionth treatment of praziquantel against schistosomiasis thanks to funding from private donations which complemented the ICOSA award from DFID.
Delivering 50 million treatments per year
The SCI reached an annual delivery of over 50 million treatments against parasitic worm infections.
200 millionth treatment delivered
By December 2018, the SCI had facilitated the delivery of its 200 millionth treatment against parasitic worm infections.